|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||
| Cash | ||||||||||
| Accounts receivable, net | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Property, plant and equipment, net | ||||||||||
| Operating lease right-of-use assets, net | ||||||||||
| Other assets | ||||||||||
| Total assets | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses | ||||||||||
| Accrued compensation | ||||||||||
| Accrued interest | ||||||||||
| Accrued stock offering expenses | ||||||||||
| Other accrued expenses | ||||||||||
| Deferred rent | ||||||||||
| Current portion of operating lease liabilities | ||||||||||
| Current portion of finance lease liabilities | ||||||||||
| Current portion of deferred revenue | ||||||||||
| Current portion of long-term debt | ||||||||||
| Total current liabilities | ||||||||||
| Long-term operating lease liabilities | ||||||||||
| Long-term finance lease liabilities | ||||||||||
| Long-term deferred rent | ||||||||||
| Long-term deferred revenue | ||||||||||
| Long-term debt | ||||||||||
| Warrant liabilities | ||||||||||
| Total liabilities | ||||||||||
| Stockholders’ equity: | ||||||||||
| Preferred stock — 10,000,000 shares authorized as of September 30, 2020 and December 31, 2019, 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019 | ||||||||||
| Preferred stock - Series A | ||||||||||
| Preferred stock - Series A-1 | ||||||||||
| Preferred stock - Series B | ||||||||||
| Preferred stock - Series C | ||||||||||
| Preferred stock - Series C-1 | ||||||||||
| Preferred stock - Series D | ||||||||||
| Total preferred stock — 10,000,000 shares authorized as of September 30, 2020 and December 31, 2019, 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019 | ||||||||||
| Common stock — $0.001 par value, 60,000,000 and 40,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively, 37,752,261 and 28,231,267 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively | ||||||||||
| Common stock - Class B- Non-voting | ||||||||||
| Common stock - Voting | ||||||||||
| Total common stock — $0.001 par value, 60,000,000 and 40,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively, 37,752,261 and 28,231,267 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Preferred stock - Series A | ||||||||||
| Preferred stock - Series A-1 | ||||||||||
| Preferred stock - Series B | ||||||||||
| Preferred stock - Series C | ||||||||||
| Preferred stock - Series C-1 | ||||||||||
| Preferred stock - Series D | ||||||||||
| Common stock - Class B- Non-voting | ||||||||||
| Common stock - Voting | ||||||||||
| Total stockholders’ equity | ||||||||||
| Total liabilities and stockholders’ equity |
Loading...